The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Liashenko E.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Iakovleva O.V.

Russian Medical Academy of Continuous Professional Education, Centre of Extrapyramidal Disorders, Moscow, Russsia

Social cognition impairments in Parkinson’s disease

Authors:

Liashenko E.A., Iakovleva O.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(9‑2): 37‑43

DOI: 10.17116/jnevro201911909237

Read: 8667 times

Download PDF (RU)
Contact the author
Table of contents

SOCIAL COGNITION IMPAIRMENTS IN PARKINSON’S DISEASE
SOCIAL COGNITION IMPAIRMENTS IN PARKINSON’S DISEASE

To cite this article:

Liashenko EA, Iakovleva OV. Social cognition impairments in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(9‑2):37‑43. (In Russ.)
https://doi.org/10.17116/jnevro201911909237

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Sleep diso­rders in patients with Lewy body deme­ntia and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):81-87
Art and creativity in Parkinson’s disease: the mysterious effe­cts of dopa­mine. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):13-20
Correlation of motor symptoms and cardiovascular dysfunction in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):59-67
Diagnosis of pathological and adaptive bala­nce changes in Parkinson’s disease to select a reha­bilitation program. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):88-94
Pote­ntial and prospects of the astragaloside IV use for age-associated diseases prevention. Russian Journal of Preventive Medi­cine. 2025;(7):94-99
Effect of uric acid on the progression of Parkinson’s disease: Myth or reality?. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):7-14
Dyna­mics of permeability of the blood-brain barrier after FUS thalamotomy acco­rding to contrast-enhanced MRI. Burdenko's Journal of Neurosurgery. 2025;(4):51-60
Change of speech diso­rders during bila­teral deep stimulation of the subthalamic nucleus of the brain in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):59-65
Oxidative stress and depression in Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):131-138
Current aspe­cts of the rela­tionship between depression and cognitive impairment in patients with Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):66-74
Abstract:

Parkinson’s disease is the second most common neurodegenerative disease of the elderly caused by the neurodegenerative process in different parts of the brain, which resulted in motor and non-motor symptoms. Investigation of non-motor symptoms of Parkinson’s disease is increasingly rising for the last years. Social cognition is a special type of cognitive process, which provides people interaction in the society and their impairment also can be observed in Parkinson’s disease. Social cognitive functions include many aspects: the theory of the mind, morality, personality changes and behavioral disorders. Each of these aspects is based on different neurophysiological, neurochemical and neuroanatomical substrates. This article is an effort to get closer to understanding of the changes, which occur in the brain of a patient with Parkinson’s disease.

Keywords:

Parkinson disease
social cognition
theory of mind
personality changes
behavioral disorders
moral behavior

Authors:

Liashenko E.A.

Kafedra nevrologii Rossiĭskoĭ meditsinskoĭ akademii poslediplomnogo obrazovaniia, Moskva;
Tsentr kstrapiramidnykh zabolevaniĭ, Moskva

Iakovleva O.V.

Russian Medical Academy of Continuous Professional Education, Centre of Extrapyramidal Disorders, Moscow, Russsia

Close metadata

References:

  1. De Rijk MC, Launer LJ, Berger K, Breteler MM, Dartigues JF, Baldereschi M, Fratiglioni L, Lobo A, Martinez-Lage J, Trenkwalder C, Hofman A. Prevalence of Parkinson’s disease in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54(11 suppl 5):21-23.
  2. Rothdach A, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: The MEMO Study. Neurology. 2000;54(5):1064-1068. https://doi.org/10.1212/wnl.54.5.1064
  3. Kish S, Shannak K, Hornykiewicz O. Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson’s Disease. New England Journal of Medicine. 1988;318(14):876-880. https://doi.org/10.1056/nejm198804073181402
  4. Elgh E, Domellöf M, Linder J, Edström M, Stenlund H, Forsgren L. Cognitive function in early Parkinson’s disease: a population-based study. Eur J Neurol. 2009;16(12):1278-1284. https://doi.org/10.1111/j.1468-1331.2009.02707.x
  5. Dirnberger G, Jahanshahi M. Executive dysfunction in Parkinson’s disease: A review. J Neuropsychol. 2013;7(2):193-224. https://doi.org/10.1111/jnp.12028
  6. Foltynie T, Brayne C, Robbins T, Barker R. The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The Cam PaI GN study. Brain. 2004;127(3):550-560. https://doi.org/10.1093/brain/awh067
  7. Burgess P, Alderman N. Executive Dysfunction. Clinical Neuropsychology. 2005;185-209. https://doi.org/10.1002/0470013338.ch9
  8. Godefroy O, Azouvi P, Robert P, Roussel M, LeGall D, Meulemans T. Dysexecutive syndrome: Diagnostic criteria and validation study. Ann Neurol. 2010;68(6):855-864. https://doi.org/10.1002/ana.22117
  9. Shamay-Tsoory S, Harari H, Aharon-Peretz J, Levkovitz Y. The role of the orbitofrontal cortex in affective theory of mind deficits in criminal offenders with psychopathic tendencies. Cortex. 2010;46(5):668-677. https://doi.org/10.1016/j.cortex.2009.04.008
  10. Freedman M, Stuss D. Theory of Mind in Parkinson’s disease. J Neurol Sci. 2011;310(1-2):225-227. https://doi.org/10.1016/j.jns.2011.06.004
  11. Shamay-Tsoory S. The Neural Bases for Empathy. The Neuroscientist. 2010;17(1):18-24. https://doi.org/10.1177/1073858410379268
  12. Paulus M. Neurobiology of decision-making: quo vadis? Cognitive Brain Research. 2005;23(1):2-10. https://doi.org/10.1016/j.cogbrainres.2005.01.001
  13. Bechara A, Damasio H, Damasio A, Lee G. Different Contributions of the Human Amygdala and Ventromedial Prefrontal Cortex to Decision-Making. Journal of Neuroscience. 1999;19(13):5473-5481. https://doi.org/10.1523/jneurosci.19-13-05473.1999
  14. Clark L, Bechara A, Damasio H, Aitken M, Sahakian B, Robbins T. Differential effects of insular and ventromedial prefrontal cortex lesions on risky decision-making. Brain. 2008;131(5):1311-1322. https://doi.org/10.1093/brain/awn066
  15. Bodden M, Mollenhauer B, Trenkwalder C, Cabanel N, Eggert KM, Unger MM, Oertel WH, Kessler J, Dodel R, Kalbe E. Affective and cognitive theory of mind in patients with parkinson’s disease. Parkinsonism Relat Disord. 2010;16(7):466-470. https://doi.org/10.1016/j.parkreldis.2010.04.014
  16. Poletti M, Vergallo A, Ulivi M, Sonnoli A, Bonuccelli U. Affective theory of mind in patients with Parkinson’s disease. Psychiatry Clin Neurosci. 2013;67(4):273-276. https://doi.org/10.1111/pcn.12045
  17. Roca M, Torralva T, Gleichgerrcht E, Chade A, Arévalo GG, Gershanik O, Manes F. Impairments in Social Cognition in Early Medicated and Unmedicated Parkinson Disease. Cognitive and Behavioral Neurology. 2010;23(3):152-158. https://doi.org/10.1097/wnn.0b013e3181e078de
  18. Péron J, Vicente S, Leray E Drapier S, Drapier D, Cohen R, Biseul I, Rouaud T, Le Jeune F, Sauleau P, Vérin M. Are dopaminergic pathways involved in theory of mind? A study in Parkinson’s disease. Neuropsychologia. 2009;47(2):406-414. https://doi.org/10.1016/j.neuropsychologia.2008.09.008
  19. Yu R, Wu R, Chiu M, Tai C, Lin C, Hua M. Advanced Theory of Mind in patients at early stage of Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(1):21-24. https://doi.org/10.1016/j.parkreldis.2011.08.003
  20. Díez-Cirarda M, Ojeda N, Peña J, Cabrera-Zubizarreta A, Gómez-Beldarrain MA, Gómez-Esteban JC, Ibarretxe-Bilbao N. Neuroanatomical Correlates of Theory of Mind Deficit in Parkinson’s Disease: A Multimodal Imaging Study. PLoS ONE. 2015;10(11):e0142234. https://doi.org/10.1371/journal.pone.0142234
  21. Bora E, Walterfang M, Velakoulis D. Theory of mind in Parkinson’s disease: A meta-analysis. Behav Brain Res. 2015;292:515-520. https://doi.org/10.1016/j.bbr.2015.07.012
  22. Brand M, Greco R, Schuster A, Kalbe E, Fujiwara E, Markowitsch HJ, Kessle J. The game of dice — a new test for the assessment of risktaking behavior. Neurorehabilitation & Neural Repair. 2002;16:142-143.
  23. Kobayakawa M, Koyama S, Mimura M, Kawamura M. Decision making in Parkinson’s disease: Analysis of behavioral and physiological patterns in the Iowa gambling task. Movement Disorders. 2008;23(4):547-552. https://doi.org/10.1002/mds.21865
  24. Mimura M, Oeda R, Kawamura M. Impaired decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2006;12(3):169-175. https://doi.org/10.1016/j.parkreldis.2005.12.003
  25. Xi C, Zhu Y, Mu Y, Chen B, Dong B, Cheng H, Hu P, Zhu C, Wang K. Theory of mind and decision-making processes are impaired in Parkinson’s disease. Behav Brain Res. 2015;279:226-233. https://doi.org/10.1016/j.bbr.2014.11.035
  26. Aguilar M, Miñarro J, Pérez-Iranzo N, Simón V. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacology Biochemistry and Behavior. 1994;47(3):753-756. https://doi.org/10.1016/0091-3057(94)90185-6
  27. Averill JR. Cross-Cultural Variations in Aggressive Syndromes. Anger and Aggression. NY: Springer; 1982.
  28. Lawrence A, Calder A, McGowan S, Grasby P. Selective disruption of the recognition of facial expressions of anger. Neuroreport. 2002;13(6):881-884. https://doi.org/10.1097/00001756-200205070-00029
  29. Lawrence A, Goerendt I, Brooks D. Impaired recognition of facial expressions of anger in Parkinson’s disease patients acutely withdrawn from dopamine replacement therapy. Neuropsychologia. 2007;45(1):65-74. https://doi.org/10.1016/j.neuropsychologia.2006.04.016
  30. Sprengelmeyer R, Young A, Mahn K, Schroeder U, Woitalla D, Büttner T, Kuhn W, Przuntek H. Facial expression recognition in people with medicated and unmedicated Parkinson’s disease. Neuropsychologia. 2003;41(8):1047-1057. https://doi.org/10.1016/s0028-3932(02)00295-6
  31. Gert B, Gert J. The Definition of Morality. The Stanford Encyclopedia of Philosophy (Fall 2017 Edition). Edward N. Zalta (ed.). Stanford: The Metaphysics Research Lab; 2017. https://plato.stanford.edu/archives/fall2017/entries/morality-definition
  32. Bradford EE, Jentzsch I, Gomez JC. From self to social cognition: Theory of Mind mechanisms and their relation to Executive Functioning. Cognition. 2015;138:21-34. https://doi.org/10.1016/j.cognition.2015.02.001
  33. Knobe J. Theory of mind and moral cognition: exploring the connections. Trends Cogn Sci (Regul Ed). 2005;9(8):357-359. https://doi.org/10.1016/j.tics.2005.06.011
  34. Boccia M, Dacquino C, Piccardi L, Cordellieri P, Guariglia C, Ferlazzo F, Ferracuti S, Giannini AM. Neural foundation of human moral reasoning: an ALE meta-analysis about the role of personal perspective. Brain Imaging Behav. 2017;11(1):278-292. https://doi.org/10.1007/s11682-016-9505-x
  35. Fumagalli M, Priori A. Functional and clinical neuroanatomy of morality. Brain. 2012;135(7):2006-2021. https://doi.org/10.1093/brain/awr334
  36. Ray N, Antonelli F, Strafella A. Imaging Impulsivity in Parkinson’s Disease and the Contribution of the Subthalamic Nucleus. Parkinsons Dis. 2011;2011:1-5. https://doi.org/10.4061/2011/594860
  37. Fumagalli M, Giannicola G, Rosa M, Marceglia S, Lucchiari C, Mrakic-Sposta S, Servello D, Pacchetti C, Porta M, Sassi M, Zangaglia R, Franzini A, Albanese A, Romito L, Piacentini S, Zago S, Pravettoni G, Barbieri S, Priori A. Conflict-dependent dynamic of subthalamic nucleus oscillations during moral decisions. Soc Neurosci. 2011;6(3):243-256. https://doi.org/10.1080/17470919.2010.515148
  38. Santangelo G, Piscopo F, Barone P, Vitale C. Personality in Parkinson’s disease: Clinical, behavioural and cognitive correlates. J Neurol Sci. 2017;374:17-25. https://doi.org/10.1016/j.jns.2017.01.013
  39. Koerts J, Tucha L, Leenders K, Tucha O. Neuropsychological and Emotional Correlates of Personality Traits in Parkinson’s Disease. Behav Neurol. 2013;27(4):567-574. https://doi.org/10.1155/2013/896387
  40. Santangelo G, Garramone F, Baiano C, D’Iorio A, Piscopo F, Raimo S, Vitale C. Personality and Parkinson’s disease: A meta-analysis. Parkinsonism Relat Disord. 2018;49:67-74. https://doi.org/10.1016/j.parkreldis.2018.01.013
  41. Ishii T, Sawamoto N, Tabu H Kawashima H, Okada T, Togashi K, Takahashi R, Fukuyama H. Altered striatal circuits underlie characteristic personality traits in Parkinson’s disease. J Neurol. 2016;263(9):1828-1839. https://doi.org/10.1007/s00415-016-8206-0
  42. Cools R, D’Esposito M. Inverted-U — Shaped Dopamine Actions on Human Working Memory and Cognitive Control. Biol Psychiatry. 2011;69(12):113-125. https://doi.org/10.1016/j.biopsych.2011.03.028
  43. Rosen J, Rott E, Ebersbach G, Kalbe E. Altered moral decision-making in patients with idiopathic Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(10):1191-1199. https://doi.org/10.1016/j.parkreldis.2015.08.016
  44. Weintraub D, Claassen D. Impulse Control and Related Disorders in Parkinson’s Disease. Int Rev Neurobiol. 2017;133:679-717. https://doi.org/10.1016/bs.irn.2017.04.006
  45. Solla P, Bortolato M, Cannas A, Mulas C, Marrosu F. Paraphilias and paraphilic disorders in Parkinson’s disease: A systematic review of the literature. Movement Disorders. 2015;30(5):604-613. https://doi.org/10.1002/mds.26157
  46. Titova N, Chaudhuri K. Personalized medicine in Parkinson’s disease: Time to be precise. Movement Disorders. 2017;32(8):1147-1154. https://doi.org/10.1002/mds.27027
  47. Schuepbach WM, Rau J, Knudsen K, Volkmann J, Krack P, Timmermann L, Hälbig TD, Hesekamp H, Navarro SM, Meier N, Falk D, Mehdorn M, Paschen S, Maarouf M, Barbe MT, Fink GR, Kupsch A, Gruber D, Schneider GH, Seigneuret E, Kistner A, Chaynes P, Ory-Magne F, Brefel Courbon C, Vesper J, Schnitzler A, Wojtecki L, Houeto JL, Bataille B, Maltête D, Damier P, Raoul S, Sixel-Doering F, Hellwig D, Gharabaghi A, Krüger R, Pinsker MO, Amtage F, Régis JM, Witjas T, Thobois S, Mertens P, Kloss M, Hartmann A, Oertel WH, Post B, Speelman H, Agid Y, Schade-Brittinger C, Deuschl G. Neurostimulation for Parkinson’s Disease with Early Motor Complications. New England Journal of Medicine. 2013;368(7):610-622. https://doi.org/10.1056/nejmoa1205158
  48. Claeys I, Santens P, Van den Abbeele D, Van Roost D, Lemmens G. A manic episode after bilateral subthalamic stimulation in a patient with advanced Parkinson’s disease. Acta Neuropsychiatr. 2013;25(06):367-369. https://doi.org/10.1017/neu.2013.30
  49. Evens R, Hoefler M, Biber K, Lueken U. The Iowa Gambling Task in Parkinson’s disease: A meta-analysis on effects of disease and medication. Neuropsychologia. 2016;91:163-172. https://doi.org/10.1016/j.neuropsychologia.2016.07.032
  50. Florin E, Müller D, Pfeifer J, Barbe M, Fink G, Timmermann L. Subthalamic stimulation modulates self-estimation of patients with Parkinson’s disease and induces risk-seeking behaviour. Brain. 2013;136(11):3271-3281. https://doi.org/10.1093/brain/awt241
  51. Schüpbach M, Gargiulo M, Welter ML, Mallet L, Béhar C, Houeto JL, Maltête D, Mesnage V, Agid Y. Neurosurgery in Parkinson disease: A distressed mind in a repaired body? Neurology. 2006;66(12):1811-1816. https://doi.org/10.1212/01.wnl.0000234880.51322.16
  52. Fumagalli M, Marceglia S, Cogiamanian F, Ardolino G, Picascia M, Barbieri S, Pravettoni G, Pacchetti C, Priori A. Ethical safety of deep brain stimulation: A study on moral decision-making in Parkinson’s disease. Parkinsonism Relat Disord. 2015;21(7):709-716. https://doi.org/10.1016/j.parkreldis.2015.04.011
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.